Ticker: BCRX

Company: BIOCRYST PHARMACEUTICALS INC

Person: Steven Frank, director

Transaction date: May 30, 2025

Reporting date: June 3, 2025

Average share price: 10.75

Bought 333.0 shares for 3579.75